Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.
Susan R. Snyder, PhD
Advertisement
Articles by Susan R. Snyder, PhD
Advertisement
Latest Updated Articles
- The Value of Value-Based Insurance Design: Savings From Eliminating Drug Co-Payments
Published: February 16th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
3
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
4
Persistent Barriers Keep Oral HIV PrEP Out of Reach for High-Risk Groups
5
